Forum Fall 2013 - page 3

Forum, Fall 2013
3
The newsletter of the Cutaneous Lymphoma Foundation
ALL RIGHTS RESERVED
MEDICAL EDITOR
Stuart Lessin, M.D.
Cutaneous Lymphoma Foundation is a 501(c)(3) non-profit organiza-
tion. Donations are tax deductible to the extent allowed by law.
Forum
Thomas Anderson, M.D.
Kevin Cooper, M.D.
Madeleine Duvic, M.D.
Francine Foss, M.D.
Lars French, M.D.
Sam Hwang, M.D., Ph.D.
Robert Knobler, M.D.
Thomas Kupper, M.D.
Liliane Laroche, M.D.
Sue McCann, MSN, RN
Lauren Pinter-Brown, M.D.
David Ramsay, M.D.
Alain Rook, M.D.
Steven T. Rosen, M.D.
Martin Weinstock, M.D., Ph.D.
Sean Whittaker, M.D., MRCP
Lynn Wilson, M. D., MPH
University of Michigan
Case Western Reserve University
MD Anderson Cancer Center
Yale University School of Medicine
Geneva Medical Center
The Medical College of Wisconsin
University of Vienna
Brigham and Women’s Hospital
University of Paris
University of Pittsburgh Medical Center
UCLA Medical Center
New York University
University of Pennsylvania
Northwestern University
Brown University
Guys & St. Thomas Hospital
Yale University School of Medicine
MEDICAL ADVISORY BOARD
Kira Mann
Holly Priebe
Susan Thornton
Deb Van Zegeren
Director of Development and Marketing
Chief Operating and Financial Officer
Chief Executive Officer
Administrative and Communications Manager
STAFF
The Cutaneous Lymphoma
Foundation welcomes Mike Silver
as the newest member of our Board
of Directors.
Mike is a Vice President at a
leading Canadian Investment
Bank, where he is responsible for
structuring and executing on M&A
and financing transactions. He has
worked in the Investment Banking
industry since 2006, having also held positions with a
Canadian bank and a U.S. based bulge bracket. Prior to
earning his MBA, Mike worked with IBM for three years
within several finance and strategy related positions.
Mike has an International MBA from the Rotterdam
School of Management, Erasmus University, in the
Netherlands, and a Bachelor of Commerce degree from
Dalhousie University in Halifax, Canada.
Mike and his family reside in Toronto, Canada.
CLF Welcomes New Board Member
BOARD OF DIRECTORS
Stuart Lessin, M.D.
Marianne Tawa, MSN, RN, ANP
Jeff Ward
Laurel Carlson
President
Vice President
Treasurer
Secretary
OFFICERS
Brace Krag
David Lamb
Pierluigi Porcu, M.D.
Christopher Shipp
Mike Silver
Michael W. Young
Director
Director
Director
Director
Director
Director
DIRECTORS
Cutaneous lymphomas are cancers of lymphocytes (white
blood cells) that primarily involve the skin. Classification
is based on lymphocyte type: B-lymphocytes (B-cell) or
T-lymphocytes (T-cell).
Cutaneous T-cell lymphoma (CTCL) is the most
common type of cutaneous lymphoma that typically
presents with red, scaly patches or thickened plaques
of skin that often mimic eczema or chronic dermatitis.
Progression from limited skin involvement is variable
and may be accompanied by tumor formation, ulceration
and exfoliation, complicated by itching and infections.
Advanced stages are defined by involvement of lymph
nodes, peripheral blood, and internal organs.
What Is Cutaneous Lymphoma?
The Cutaneous Lymphoma Foundation’s patient
educational newsletter,
Forum
, has been
made possible thanks to the following
generous supporters:
1,2 4,5,6,7,8,9,10,11,12
Powered by FlippingBook